Quick Answer
Lexaria Bioscience Corp. reported Common Stock Shares Outstanding of 19.56 million shares for the year ending 2025.
- Lexaria Bioscience Corp. showed an increase of +23.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Lexaria Bioscience Corp.'s annual report (Form 10-K), filed with the SEC on November 28, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Lexaria Bioscience Corp.'s Common Stock Shares Outstanding has grown by 51.3%.
- Historical annual values: Fiscal year 2025: 19.56 million shares | Fiscal year 2024: 15.81 million shares | Fiscal year 2023: 8.09 million shares | Fiscal year 2022: 5.95 million shares | Fiscal year 2021: 5.73 million shares | Fiscal year 2020: 3.00 million shares | Fiscal year 2019: 78.79 million shares | Fiscal year 2018: 75.53 million shares | Fiscal year 2017: 67.98 million shares | Fiscal year 2016: 51.29 million shares | Fiscal year 2015: 43.84 million shares | Fiscal year 2014: 34.25 million shares | Fiscal year 2013: 16.43 million shares | Fiscal year 2012: 16.43 million shares | Fiscal year 2011: 16.43 million shares | Fiscal year 2010: 12.93 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: